NEW YORK, October 31, 2016 /PRNewswire/ --
The medical device and technology markets are facing global challengeslike escalating consolidation, conflicts with insurance companies, as well as political and economic uncertainties in China and Europe. Despite these challenges, a research report by Evaluate
The drop in sales witnessed in the medical device and technology markets from 2014 to 2015 resulted in 12 out the 20 largest companies in the market to have negative growth, according to Evaluate's research. This in turn caused several "mega mergers" and cost cuts. In the first half of 2016 mergers and acquisitions activities dropped nearly 80%, indicating that consolidation will no longer be an issue to worry about and partially due to resumed growth. Ian Strickland, EvaluateMedTech product manager said, "The device industry is growing reasonably rapidly, and the calming of the M&A scene does not pose a problem for the expected growth."
A small company making noise in this sector, Medovex Corp. (NASDAQ: MDVX) is biomedical device company with the mission of acquiring and developing a portfolio of potentially ground breaking medical technology products. According to the company, they focus on products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at a much lower cost than other currently available treatments.
Recently on October 13th Medovex Corp. announced that the company successfully exhibited its' DenerveX System during EuroSpine 2016 Tradeshow last week in Berlin, Germany. The event marked the official opening of the Company's European Distribution Center in Berlin. The new distribution service headquarters will function as a commercial hub for all European distributors, as well as other customer and technical support services, while international operations center and the company's global operational headquarters will remain in Atlanta, Georgia.
Patrick Kullmann, President and COO for Medovex Corp., said in a statement, "We consider EuroSpine 2016 in Berlin our 'pre-launch' meeting leading up to what is expected to be an eventual formal CE Marking. In particular, we were very pleased to see visiting surgeons and distributors from more than 25 countries, and from all continents, at our booth, along with existing and new potential distributors visiting with us."
Boston Scientific Corporation (NYSE: BSX) is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The company manufactures devices such as defibrillators, direct visualization systems, remote monitoring devices, and many more. Earlier this August, Boston Scientific has announced the FDA approval of the EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System.
Zimmer Biomet Holdings Inc. (NYSE: ZBH) is engaged designing, manufacturing and marketing a wide range of medically relevant products, including orthopaedic reconstructive products, sports medicine, biologics, extremities and trauma products, as well as spine and bone healing, and more. Recently the company announced the acquisition of RespondWell, an award-winning telerehabilitation technology designed to provide clinician-supervised post-surgical physical therapy in the comfort of a patient's home.
Medtronic PLC (NYSE: MDT) is a medical technology and services company focused on development, manufacturing and marketing of medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. This October the Medtronic announced the an FDA approval and U.S. launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest sized transcatheter aortic valve replacement system available in the U.S. The new Evolut R 34 mm valve is approved for severe aortic stenosis patients who are at high or extreme risk for surgery.
Baxter International Inc. (NYSE: BAX) owns a portfolio of essential renal and hospital products, including home, acute and in-center dialysis, sterile intravenous (IV) solutions, infusion systems and more. The company also provides products and services related to pharmacy compounding, and drug formulation. This month Baxter announced the global launch of HDx enabled by THERANOVA, a new type of hemodialysis therapy that provides high performance treatments with integration into existing healthcare infrastructure. Baxter will launch HDx enabled by THERANOVA in Australia, New Zealand, France, Germany, Switzerland and Belgium this year.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: Media Contact: Danny A, email@example.com , +1-877-601-1879 URL: http://www.FinancialBuzz.com
Subscribe to our Free Newsletters!